Javier Arenas, MD
Urology · El Paso, TXNPI 1508083387
Payments from drug & device makers
Across 38 payments — averaging $228.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Boston Scientific$733
- Gilead$71
- Olympus Corporation Of The Americas$65
- Teleflex LLC$47
- Ferring Pharmaceuticals Inc.$36
- plus $71 from 3 others
What the payments were for
- Travel & lodging$2,91834%
- Food & beverage$1,21314%
- Education$4,53552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $7,643 |
| Boston Scientific | 11 | $733 |
| Gilead | 1 | $71 |
| Olympus Corporation Of The Americas | 1 | $65 |
| Teleflex LLC | 1 | $47 |
| Ferring Pharmaceuticals Inc. | 1 | $36 |
| AstraZeneca | 1 | $35 |
| AbbVie | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$4,500
- Da Vinci Surgical System$2,631
- GENERAL BPH$381
- Bulkamid$132
How this compares
$8,666 in reported general payments places this provider in the 70th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 350 | $418,587 |
| Methenamine Hippurate | 214 | $28,637 |
| Tamsulosin Hcl | 2,121 | $27,600 |
| GemtesaVibegron | 19 | $26,027 |
| Finasteride | 1,809 | $23,927 |
| Mirabegron ErMirabegron | 18 | $15,187 |
| Solifenacin Succinate | 284 | $15,039 |
| Fosfomycin Tromethamine | 38 | $11,699 |
| Estradiol | 124 | $9,876 |
| PremarinEstrogens, Conjugated | 12 | $7,878 |
| Trimethoprim | 95 | $4,842 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 88 | $3,482 |
| Bethanechol Chloride | 27 | $3,151 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 64 | $2,968 |
| Oxybutynin Chloride | 149 | $2,742 |
Paid to pharmacies, not to this prescriber.
Other urology in El Paso
- Daniel VoglewedeEl Paso$380K
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.